Airbus is maintaining its full-year delivery estimate and its longer-term production ramp-up targets, although it states that supply-chain ... with Airbus set to pick up the A350 programme work.

Ashwin Ramaswami, a young Democrat from Johns Creek, is challenging the incumbent state senator, who was indicted alongside former President Trump for alleged interference in Georgia's 2020 election.

This website uses cookies to improve your experience. By continuing to use this website you are accepting our cookie policy. Some cookies are necessary to make the website work properly, for example ...

Agence France-Presse, Andrew Caballero-Reynolds with Issam Ahmed in Washington ...

American Airlines is testing new technology to end a process known as "gate lice," which is when passengers cut lines in hopes of boarding a flight early. The system audibly flags when a passenger ...

The mid-cap biotech has already received up-front payments from Vertex for some of the rights (60%) to Casgevy's profits. CRISPR Therapeutics will also benefit from Vertex's expertise in ...

Competitive landscape: In China's molecular diagnostics industry, foreign companies such as Roche, Abbott and Siemens are still in the leading position, while domestic companies such as BGI, Kehua ...

The event is free to attend and runs from 10:00 AM to 9:00 PM each day. Get ready for a weekend of American food, drinks, and fun at the “What’s Up! Bangkok” event! Happening from October 25 ...

Every element of the limited-edition appliance was thought through and intended to set it apart from other ... appliances of its ilk, The Smart Fridge lives up to its name with useful in-app ...

Sony Interactive Entertainment Japan Asia will host PlayStation Partner Awards 2024 Japan Asia on December 3, the company announced. PlayStation Partner Awards 2024 Japan Asia recognizes the ...

But that dropped to between 1.5 million and 1.6 million vehicles between 2020 and 2023 as pandemic-related supply chain problems held up the production of new vehicles. That means about a million ...

That's in addition to the standard set of biotech stock risks, including a substantial chance of Wave's clinical trials failing to deliver good data. It will be years before this company can ...